Prevention of chronic lung disease (CLD) in premature infants with early dexamethasone therapy

Pediatric Pulmonology

Volumn 24, Issue SUPPL. 16, 1997, Pages 35-36

  Yeh, T F ^a  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; LUNG SURFACTANT; ANTIINFLAMMATORY AGENT;

ARTIFICIAL VENTILATION; CHRONIC LUNG DISEASE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; HUMAN; INFANT; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NEONATAL RESPIRATORY DISTRESS SYNDROME; PREMATURITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ARTICLE; CHRONIC DISEASE; COMPARATIVE STUDY; DOSE RESPONSE; FEMALE; LUNG DISEASE; MALE; NEWBORN; SURVIVAL RATE; TREATMENT OUTCOME;

ANTI-INFLAMMATORY AGENTS; CHRONIC DISEASE; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; LUNG DISEASES; MALE; RESPIRATORY DISTRESS SYNDROME, NEWBORN; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0031298397     PISSN: 87556863     EISSN: None     Source Type: Journal    
DOI: 10.1002/ppul.1950230819     Document Type: Conference Paper

References (9)

1. Saugstad OD. Oxygen toxicity in the neonatal period. Acta Paediatr. Scand. 1990; 79:881-892.
2. Groneck P, Speer CP. Inflammatory mediators and bronchopulmonary dysplasia. Arch Dis Child. 1995; 73:F1-F3.
3. Groneck P, Gotze-speer B, Oppermann M, Eiffert H, Speer CP. Association of pulmonary inflammation and increased microvascular permeability during the development of bronchopulmonary dysplasia: a sequential analysis of inflammatory mediators in respiratory fluid of high risk preterm infants. Pediatrics. 1994; 93:712-718.
4. Mammel MC, Green TP, Johnson DE, Thompson TR. Controlled trial of Dexamethasone therapy in infants with bronchopulmonary dysplasia. Lancet. 1983; 1:1356-1358.
5. Avery GB, Fletchen AB, Kaplan M, Brudne DS. Controlled trial of dexamethasone in respirator dependent infants with bronchopulmonary dysplasia. 1985; 75:106-111.
6. Cummings JJ, D'Eugenio DB, Gross SJ. A controlled trial of dexamethasone in premature infants at high risk for bronchopulmonary dysplasia. N Engl J Med. 1989; 320:1505-1510.
7. Rosamond J, and Collaborative Dexamethasone Trial Group. Dexamethasone therapy in neonatal chronic lung disease: an international placebo-controlled trial. Pediatrics. 1991; 88:421-427.
8. Yeh TF, Torre J, Rastogi A, Anyebuno M, Lildes RS. Early postnatal dexamethasone therapy in premature infants with severe respiratory distress syndrome: A double-blind controlled study. J Pediatr. 1990; 117:273-282.
9. Sanders RJ, Cox C, Phelps DL, Sinkin RA. Two doses of early intravenous dexamethasone for the prevention of bronchopulmonary dysplasia on babies with respiratory distress syndrome. Pediatr Res. 1994; 36:122-128.